180 related articles for article (PubMed ID: 22920631)
1. Innate immunity in the pathogenesis of cholangiopathy: a recent update.
Harada K; Nakanuma Y
Inflamm Allergy Drug Targets; 2012 Dec; 11(6):478-83. PubMed ID: 22920631
[TBL] [Abstract][Full Text] [Related]
2. Biliary innate immunity in the pathogenesis of biliary diseases.
Harada K; Nakanuma Y
Inflamm Allergy Drug Targets; 2010 Jun; 9(2):83-90. PubMed ID: 20402650
[TBL] [Abstract][Full Text] [Related]
3. [Pathogenesis of biliary tract injury in primary biliary cirrhosis].
Ishibashi H; Shimoda S
Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(6):455-62. PubMed ID: 23291480
[TBL] [Abstract][Full Text] [Related]
4. Biliary innate immunity: function and modulation.
Harada K; Nakanuma Y
Mediators Inflamm; 2010; 2010():. PubMed ID: 20798866
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.
Strazzabosco M; Fiorotto R; Cadamuro M; Spirli C; Mariotti V; Kaffe E; Scirpo R; Fabris L
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1374-1379. PubMed ID: 28754453
[TBL] [Abstract][Full Text] [Related]
6. Monocyte chemoattractant protein-1 derived from biliary innate immunity contributes to hepatic fibrogenesis.
Harada K; Chiba M; Okamura A; Hsu M; Sato Y; Igarashi S; Ren XS; Ikeda H; Ohta H; Kasashima S; Kawashima A; Nakanuma Y
J Clin Pathol; 2011 Aug; 64(8):660-5. PubMed ID: 21527401
[TBL] [Abstract][Full Text] [Related]
7. Significance of periductal Langerhans cells and biliary epithelial cell-derived macrophage inflammatory protein-3α in the pathogenesis of primary biliary cirrhosis.
Harada K; Shimoda S; Ikeda H; Chiba M; Hsu M; Sato Y; Kobayashi M; Ren XS; Ohta H; Kasashima S; Kawashima A; Nakanuma Y
Liver Int; 2011 Feb; 31(2):245-53. PubMed ID: 21092071
[TBL] [Abstract][Full Text] [Related]
8. The immunophysiology and apoptosis of biliary epithelial cells: primary biliary cirrhosis and primary sclerosing cholangitis.
Kawata K; Kobayashi Y; Gershwin ME; Bowlus CL
Clin Rev Allergy Immunol; 2012 Dec; 43(3):230-41. PubMed ID: 22689287
[TBL] [Abstract][Full Text] [Related]
9. Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis.
Shimoda S; Harada K; Niiro H; Shirabe K; Taketomi A; Maehara Y; Tsuneyama K; Nakanuma Y; Leung P; Ansari AA; Gershwin ME; Akashi K
Hepatology; 2011 Apr; 53(4):1270-81. PubMed ID: 21400555
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis.
Sasaki M; Miyakoshi M; Sato Y; Nakanuma Y
J Hepatol; 2010 Aug; 53(2):318-25. PubMed ID: 20570384
[TBL] [Abstract][Full Text] [Related]
11. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis.
Dienes HP; Lohse AW; Gerken G; Schirmacher P; Gallati H; Löhr HF; Meyer zum Büschenfelde KH
Virchows Arch; 1997 Aug; 431(2):119-24. PubMed ID: 9293893
[TBL] [Abstract][Full Text] [Related]
12. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis.
Harada K; Shimoda S; Sato Y; Isse K; Ikeda H; Nakanuma Y
Clin Exp Immunol; 2009 Aug; 157(2):261-70. PubMed ID: 19604266
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis.
Cruickshank SM; Southgate J; Wyatt JI; Selby PJ; Trejdosiewicz LK
J Clin Pathol; 1999 Oct; 52(10):730-4. PubMed ID: 10674028
[TBL] [Abstract][Full Text] [Related]
14. Biliary innate immunity and cholangiopathy.
Harada K; Nakanuma Y
Hepatol Res; 2007 Oct; 37 Suppl 3():S430-7. PubMed ID: 17931198
[TBL] [Abstract][Full Text] [Related]
15. Chemokine-chemokine receptor CCL2-CCR2 and CX3CL1-CX3CR1 axis may play a role in the aggravated inflammation in primary biliary cirrhosis.
Sasaki M; Miyakoshi M; Sato Y; Nakanuma Y
Dig Dis Sci; 2014 Feb; 59(2):358-64. PubMed ID: 24185682
[TBL] [Abstract][Full Text] [Related]
16. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
Chung BK; Karlsen TH; Folseraas T
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition induced by biliary innate immunity contributes to the sclerosing cholangiopathy of biliary atresia.
Harada K; Sato Y; Ikeda H; Isse K; Ozaki S; Enomae M; Ohama K; Katayanagi K; Kurumaya H; Matsui A; Nakanuma Y
J Pathol; 2009 Apr; 217(5):654-64. PubMed ID: 19116990
[TBL] [Abstract][Full Text] [Related]
18. Studies on cellular immunity against bile proteins in primary biliary cirrhosis by the leukocyte migration inhibition test (microdroplet method).
Fujiwara R; Tobe K; Nagashima H
Acta Med Okayama; 1986 Feb; 40(1):17-25. PubMed ID: 3083652
[TBL] [Abstract][Full Text] [Related]
19. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways.
Yokoyama T; Komori A; Nakamura M; Takii Y; Kamihira T; Shimoda S; Mori T; Fujiwara S; Koyabu M; Taniguchi K; Fujioka H; Migita K; Yatsuhashi H; Ishibashi H
Liver Int; 2006 May; 26(4):467-76. PubMed ID: 16629651
[TBL] [Abstract][Full Text] [Related]
20. Autophagy and senescence in fibrosing cholangiopathies.
Nakanuma Y; Sasaki M; Harada K
J Hepatol; 2015 Apr; 62(4):934-45. PubMed ID: 25435435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
